Shares of Aurobindo Pharma Ltd. gained as much as 2% on Thursday, February 26, after the company announced that its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the US Food and Drug Administration for Everolimus Tablets.The approval allows Eugia Unit I to...
anda approval
aurobindo pharma
eugia pharma specialities
european revenue growth
everolimus tablets
generic drugs
iqvia market data
kidney transplant
liver transplant
oncology drugs
organ transplantation
pharmaceutical manufacturing
pharmaceuticalsales
research and development
us food and drug administration
Lupin Receives USFDA Nod for Seizure Treatment Drug
Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
anda
brivaracetam
briviact
bse
drug approval
generic medication
india
lupin
oral solution
pharmaceutical industry
pharmaceuticalsales
seizures
us market
usfda
